Report Detail
Global Addison's Disease Treatment Market Growth (Status and Outlook) 2019-2024
- RnM3197730 |
- 27 March, 2019 |
- Global |
- 118 Pages |
- LPI(LP Information) |
- Other
Addison's disease, also known as primary adrenal insufficiency and hypocortisolism, is a long-term endocrine disorder in which the adrenal glands do not produce enough steroid hormones. Symptoms generally come on slowly and may include abdominal pain, weakness, and weight loss. Darkening of the skin in certain areas may also occur. Under certain circumstances, an adrenal crisis may occur with low blood pressure, vomiting, lower back pain, and loss of consciousness. An adrenal crisis can be triggered by stress, such as from an injury, surgery, or infection.
According to this study, over the next five years the Addison's Disease Treatment market will register a xx% CAGR in terms of revenue, the global market size will reach US$ xx million by 2024, from US$ xx million in 2019. In particular, this report presents the global revenue market share of key companies in Addison's Disease Treatment business, shared in Chapter 3.
This report presents a comprehensive overview, market shares and growth opportunities of Addison's Disease Treatment market by product type, application, key companies and key regions.
This study considers the Addison's Disease Treatment value generated from the sales of the following segments:
Segmentation by product type: breakdown data from 2014 to 2019 in Section 2.3; and forecast to 2024 in section 10.7.
Oral Corticosteroid
Corticosteroid Injections
Segmentation by application: breakdown data from 2014 to 2019, in Section 2.4; and forecast to 2024 in section 10.8.
Hospitals
Clinics
Others
This report also splits the market by region: Breakdown data in Chapter 4, 5, 6, 7 and 8.
Americas
United States
Canada
Mexico
Brazil
APAC
China
Japan
Korea
Southeast Asia
India
Australia
Europe
Germany
France
UK
Italy
Russia
Spain
Middle East & Africa
Egypt
South Africa
Israel
Turkey
GCC Countries
The report also presents the market competition landscape and a corresponding detailed analysis of the major vendor/manufacturers in the market. The key manufacturers covered in this report: Breakdown data in in Chapter 3.
Pfizer
GlaxoSmithKline
Shire
Abbott Laboratories
Merck
Boehringer Ingelheim
Amgen
Lupin Pharmaceuticals
In addition, this report discusses the key drivers influencing market growth, opportunities, the challenges and the risks faced by key players and the market as a whole. It also analyzes key emerging trends and their impact on present and future development.
Research objectives
To study and analyze the global Addison's Disease Treatment market size by key regions/countries, product type and application, history data from 2014 to 2018, and forecast to 2024.
To understand the structure of Addison's Disease Treatment market by identifying its various subsegments.
Focuses on the key global Addison's Disease Treatment players, to define, describe and analyze the value, market share, market competition landscape, SWOT analysis and development plans in next few years.
To analyze the Addison's Disease Treatment with respect to individual growth trends, future prospects, and their contribution to the total market.
To share detailed information about the key factors influencing the growth of the market (growth potential, opportunities, drivers, industry-specific challenges and risks).
To project the size of Addison's Disease Treatment submarkets, with respect to key regions (along with their respective key countries).
To analyze competitive developments such as expansions, agreements, new product launches and acquisitions in the market.
To strategically profile the key players and comprehensively analyze their growth strategies.
Table of Contents
2019-2024 Global Addison's Disease Treatment Market Report (Status and Outlook)
1 Scope of the Report
- 1.1 Market Introduction
- 1.2 Research Objectives
- 1.3 Years Considered
- 1.4 Market Research Methodology
- 1.5 Economic Indicators
- 1.6 Currency Considered
2 Executive Summary
- 2.1 World Market Overview
- 2.1.1 Global Addison's Disease Treatment Market Size 2014-2024
- 2.1.2 Addison's Disease Treatment Market Size CAGR by Region
- 2.2 Addison's Disease Treatment Segment by Type
- 2.2.1 Oral Corticosteroid
- 2.2.2 Corticosteroid Injections
- 2.3 Addison's Disease Treatment Market Size by Type
- 2.3.1 Global Addison's Disease Treatment Market Size Market Share by Type (2014-2019)
- 2.3.2 Global Addison's Disease Treatment Market Size Growth Rate by Type (2014-2019)
- 2.4 Addison's Disease Treatment Segment by Application
- 2.4.1 Hospitals
- 2.4.2 Clinics
- 2.4.3 Others
- 2.5 Addison's Disease Treatment Market Size by Application
- 2.5.1 Global Addison's Disease Treatment Market Size Market Share by Application (2014-2019)
- 2.5.2 Global Addison's Disease Treatment Market Size Growth Rate by Application (2014-2019)
3 Global Addison's Disease Treatment by Players
- 3.1 Global Addison's Disease Treatment Market Size Market Share by Players
- 3.1.1 Global Addison's Disease Treatment Market Size by Players (2017-2019)
- 3.1.2 Global Addison's Disease Treatment Market Size Market Share by Players (2017-2019)
- 3.2 Global Addison's Disease Treatment Key Players Head office and Products Offered
- 3.3 Market Concentration Rate Analysis
- 3.3.1 Competition Landscape Analysis
- 3.3.2 Concentration Ratio (CR3, CR5 and CR10) (2017-2019)
- 3.4 New Products and Potential Entrants
- 3.5 Mergers & Acquisitions, Expansion
4 Addison's Disease Treatment by Regions
- 4.1 Addison's Disease Treatment Market Size by Regions
- 4.2 Americas Addison's Disease Treatment Market Size Growth
- 4.3 APAC Addison's Disease Treatment Market Size Growth
- 4.4 Europe Addison's Disease Treatment Market Size Growth
- 4.5 Middle East & Africa Addison's Disease Treatment Market Size Growth
5 Americas
- 5.1 Americas Addison's Disease Treatment Market Size by Countries
- 5.2 Americas Addison's Disease Treatment Market Size by Type
- 5.3 Americas Addison's Disease Treatment Market Size by Application
- 5.4 United States
- 5.5 Canada
- 5.6 Mexico
- 5.7 Key Economic Indicators of Few Americas Countries
6 APAC
- 6.1 APAC Addison's Disease Treatment Market Size by Countries
- 6.2 APAC Addison's Disease Treatment Market Size by Type
- 6.3 APAC Addison's Disease Treatment Market Size by Application
- 6.4 China
- 6.5 Japan
- 6.6 Korea
- 6.7 Southeast Asia
- 6.8 India
- 6.9 Australia
- 6.10 Key Economic Indicators of Few APAC Countries
7 Europe
- 7.1 Europe Addison's Disease Treatment by Countries
- 7.2 Europe Addison's Disease Treatment Market Size by Type
- 7.3 Europe Addison's Disease Treatment Market Size by Application
- 7.4 Germany
- 7.5 France
- 7.6 UK
- 7.7 Italy
- 7.8 Russia
- 7.9 Spain
- 7.10 Key Economic Indicators of Few Europe Countries
8 Middle East & Africa
- 8.1 Middle East & Africa Addison's Disease Treatment by Countries
- 8.2 Middle East & Africa Addison's Disease Treatment Market Size by Type
- 8.3 Middle East & Africa Addison's Disease Treatment Market Size by Application
- 8.4 Egypt
- 8.5 South Africa
- 8.6 Israel
- 8.7 Turkey
- 8.8 GCC Countries
9 Market Drivers, Challenges and Trends
- 9.1 Market Drivers and Impact
- 9.1.1 Growing Demand from Key Regions
- 9.1.2 Growing Demand from Key Applications and Potential Industries
- 9.2 Market Challenges and Impact
- 9.3 Market Trends
10 Global Addison's Disease Treatment Market Forecast
- 10.1 Global Addison's Disease Treatment Market Size Forecast (2019-2024)
- 10.2 Global Addison's Disease Treatment Forecast by Regions
- 10.2.1 Global Addison's Disease Treatment Forecast by Regions (2019-2024)
- 10.2.2 Americas Market Forecast
- 10.2.3 APAC Market Forecast
- 10.2.4 Europe Market Forecast
- 10.2.5 Middle East & Africa Market Forecast
- 10.3 Americas Forecast by Countries
- 10.3.1 United States Market Forecast
- 10.3.2 Canada Market Forecast
- 10.3.3 Mexico Market Forecast
- 10.3.4 Brazil Market Forecast
- 10.4 APAC Forecast by Countries
- 10.4.1 China Market Forecast
- 10.4.2 Japan Market Forecast
- 10.4.3 Korea Market Forecast
- 10.4.4 Southeast Asia Market Forecast
- 10.4.5 India Market Forecast
- 10.4.6 Australia Market Forecast
- 10.5 Europe Forecast by Countries
- 10.5.1 Germany Market Forecast
- 10.5.2 France Market Forecast
- 10.5.3 UK Market Forecast
- 10.5.4 Italy Market Forecast
- 10.5.5 Russia Market Forecast
- 10.5.6 Spain Market Forecast
- 10.6 Middle East & Africa Forecast by Countries
- 10.6.1 Egypt Market Forecast
- 10.6.2 South Africa Market Forecast
- 10.6.3 Israel Market Forecast
- 10.6.4 Turkey Market Forecast
- 10.6.5 GCC Countries Market Forecast
- 10.7 Global Addison's Disease Treatment Forecast by Type
- 10.8 Global Addison's Disease Treatment Forecast by Application
11 Key Players Analysis
- 11.1 Pfizer
- 11.1.1 Company Details
- 11.1.2 Addison's Disease Treatment Product Offered
- 11.1.3 Pfizer Addison's Disease Treatment Revenue, Gross Margin and Market Share (2017-2019)
- 11.1.4 Main Business Overview
- 11.1.5 Pfizer News
- 11.2 GlaxoSmithKline
- 11.2.1 Company Details
- 11.2.2 Addison's Disease Treatment Product Offered
- 11.2.3 GlaxoSmithKline Addison's Disease Treatment Revenue, Gross Margin and Market Share (2017-2019)
- 11.2.4 Main Business Overview
- 11.2.5 GlaxoSmithKline News
- 11.3 Shire
- 11.3.1 Company Details
- 11.3.2 Addison's Disease Treatment Product Offered
- 11.3.3 Shire Addison's Disease Treatment Revenue, Gross Margin and Market Share (2017-2019)
- 11.3.4 Main Business Overview
- 11.3.5 Shire News
- 11.4 Abbott Laboratories
- 11.4.1 Company Details
- 11.4.2 Addison's Disease Treatment Product Offered
- 11.4.3 Abbott Laboratories Addison's Disease Treatment Revenue, Gross Margin and Market Share (2017-2019)
- 11.4.4 Main Business Overview
- 11.4.5 Abbott Laboratories News
- 11.5 Merck
- 11.5.1 Company Details
- 11.5.2 Addison's Disease Treatment Product Offered
- 11.5.3 Merck Addison's Disease Treatment Revenue, Gross Margin and Market Share (2017-2019)
- 11.5.4 Main Business Overview
- 11.5.5 Merck News
- 11.6 Boehringer Ingelheim
- 11.6.1 Company Details
- 11.6.2 Addison's Disease Treatment Product Offered
- 11.6.3 Boehringer Ingelheim Addison's Disease Treatment Revenue, Gross Margin and Market Share (2017-2019)
- 11.6.4 Main Business Overview
- 11.6.5 Boehringer Ingelheim News
- 11.7 Amgen
- 11.7.1 Company Details
- 11.7.2 Addison's Disease Treatment Product Offered
- 11.7.3 Amgen Addison's Disease Treatment Revenue, Gross Margin and Market Share (2017-2019)
- 11.7.4 Main Business Overview
- 11.7.5 Amgen News
- 11.8 Lupin Pharmaceuticals
- 11.8.1 Company Details
- 11.8.2 Addison's Disease Treatment Product Offered
- 11.8.3 Lupin Pharmaceuticals Addison's Disease Treatment Revenue, Gross Margin and Market Share (2017-2019)
- 11.8.4 Main Business Overview
- 11.8.5 Lupin Pharmaceuticals News
12 Research Findings and Conclusion
Summary:
Get latest Market Research Reports on Addison's Disease Treatment . Industry analysis & Market Report on Addison's Disease Treatment is a syndicated market report, published as Global Addison's Disease Treatment Market Growth (Status and Outlook) 2019-2024. It is complete Research Study and Industry Analysis of Addison's Disease Treatment market, to understand, Market Demand, Growth, trends analysis and Factor Influencing market.
REPORT YOU MIGHT BE INTERESTED
Related Reports
Reason to Buy
Reports and Markets
Contact Us
+1-352-353-0818 (US)Newsletter
KEEP UP TO DATE ON ALL THE LATEST REPORTS
